Vanguard Group
AEMD icon

Vanguard Group’s Aethlon Medical AEMD Stock Holding History

Vanguard Group’s Portfolio AEMD Stock Details AEMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-265
Closed -$7.6K – 4275
2025
Q1 		$7.6K Hold
265
– – ﹤0.01% 4262
2024
Q4 		$18.3K Hold
265
– – ﹤0.01% 4263
2024
Q3 		$9.89K Hold
265
– – ﹤0.01% 4324
2024
Q2 		$10.6K Hold
265
– – ﹤0.01% 4389
2024
Q1 		$35.7K Hold
265
– – ﹤0.01% 4348
2023
Q4 		$46.5K Buy
265
+27
+11% +$3.84K ﹤0.01% 4379
2023
Q3 		$43K Sell
238
-10
-4% -$2.57K ﹤0.01% 4426
2023
Q2 		$71.3K Hold
248
– – ﹤0.01% 4420
2023
Q1 		$75.8K Sell
248
-7
-3% -$2.63K ﹤0.01% 4426
2022
Q4 		$56.2K Sell
255
-1,061
-81% -$387K ﹤0.01% 4435
2022
Q3 		$613K Buy
1,316
+698
+113% +$604K ﹤0.01% 4160
2022
Q2 		$554K Hold
618
– – ﹤0.01% 4265
2022
Q1 		$722K Sell
618
-62
-9% -$74K ﹤0.01% 4301
2021
Q4 		$1.01M Sell
680
-40
-6% -$91.1K ﹤0.01% 4263
2021
Q3 		$2.23M Sell
720
-5
-0.7% -$16.8K ﹤0.01% 4032
2021
Q2 		$2.85M Buy
725
+511
+239% +$1.18M ﹤0.01% 3853
2021
Q1 		$347K Hold
214
– – ﹤0.01% 4189
2020
Q4 		$423K Buy
214
+61
+40% +$81.5K ﹤0.01% 3983
2020
Q3 		$165K Hold
153
– – ﹤0.01% 3970
2020
Q2 		$249K Hold
153
– – ﹤0.01% 3894
2020
Q1 		$186K Buy
153
+136
+800% +$230K ﹤0.01% 3871
2019
Q4 		$13K Sell
17
-2
-11% -$4.78K ﹤0.01% 4107
2019
Q3 		$53K Sell
19
-15
-44% -$52K ﹤0.01% 4081
2019
Q2 		$147K Sell
34
-1
-3% -$6.7K ﹤0.01% 4013
2019
Q1 		$404K Buy
35
+1
+3% +$14.2K ﹤0.01% 3811
2018
Q4 		$684K Sell
34
-11
-24% -$159K ﹤0.01% 3665
2018
Q3 		$636K Hold
45
– – ﹤0.01% 3809
2018
Q2 		$689K Buy
45
+1
+2% +$15.7K ﹤0.01% 3776
2018
Q1 		$633K Buy
44
+7
+19% +$124K ﹤0.01% 3742
2017
Q4 		$501K Buy
37
+19
+106% +$231K ﹤0.01% 3749
2017
Q3 		$331K Buy
18
+12
+200% +$258K ﹤0.01% 3823
2017
Q2 		$157K Sell
6
-2
-25% -$51.7K ﹤0.01% 3936
2017
Q1 		$310K Hold
8
– – ﹤0.01% 3833
2016
Q4 		$398K Buy
8
+1
+14% +$56K ﹤0.01% 3774
2016
Q3 		$429K Buy
7
+1
+17% +$70K ﹤0.01% 3786
2016
Q2 		$406K Hold
6
– – ﹤0.01% 3825
2016
Q1 		$389K Hold
6
– – ﹤0.01% 3842
2015
Q4 		$470K Buy
6
+3
+100% +$254K ﹤0.01% 3849
2015
Q3 		$283K Buy
+3
New +$302K ﹤0.01% 3975

Other funds holding AEMD

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Vanguard Group's AEMD Position: Q2 2025 in Review

Vanguard Group sold out of Aethlon Medical (AEMD) in Q2 2025, closing a stake of 265 shares — an estimated $7.6K sold.

Vanguard Group first reported a position in AEMD in Q3 2015 and held it in 39 quarters. The position peaked at $2.85M in Q2 2021. 14 funds tracked by Wall St. Rank hold AEMD as of Q2 2025.

  • Vanguard Group reported no remaining Aethlon Medical position as of Q2 2025 after selling out during the quarter.
  • Vanguard Group sold 265 Aethlon Medical shares in Q2 2025, an estimated $7.6K.
  • Vanguard Group first reported a position in Aethlon Medical in Q3 2015 and held it in 39 quarters.
  • Vanguard Group's Aethlon Medical position peaked at $2.85M in Q2 2021.
  • 14 funds tracked by Wall St. Rank held Aethlon Medical as of Q2 2025.

Based on Vanguard Group's 13F filing for Q2 2025, filed 11 Aug 2025.